Pal International, a global leader in infection control products, and Mastermind Translations, a specialised language service provider for life science industries, have announced a strategic collaboration aimed at streamlining multilingual efforts for Pal International’s presence in over 50 overseas markets. 

This partnership was born out of a shared commitment to excellence, quality, and innovation. Last year, Pal International approached Mastermind Translations to translate its regulatory documentation.

Mastermind Translations not only provided the translations but also offered valuable suggestions to ensure compliance with the latest EU regulation for Class IIa medical devices. This added value was highly appreciated by Pal International, leading to the expansion of the collaboration to several more multilingual projects.

Distinguished by its exclusive focus on life sciences, Mastermind Translations offers life science organisations a unique combination of in-depth industry knowledge and regulatory expertise. This bespoke offering enables the Mastermind team to go well beyond a conventional translation service and deliver comprehensive linguistic solutions tailored specifically to the complex needs of clients operating in highly regulated industries, such as medical devices and pharmaceuticals.

Katarzyna E Slobodzian-Taylor, Director of Mastermind Translations, said: “At Mastermind Translations, we pride ourselves on being a value-added translation service. Our expertise in life science industries means we can support our clients with practical assistance, from advising on regulatory compliance of documentation to liaising with competent authorities in the target markets to managing regulated terminology across multilingual projects.”

The positive feedback received from Pal International further underscores the efficiency of Mastermind Translations’ work.

Pal International’s Regulatory Affairs Manager said: “We are very pleased with the exceptional quality and speedy turnaround provided by Mastermind Translations. Our Italian partners have confirmed the excellence of the translations, while our Portuguese partners have described them as ‘perfect’.”

“We are delighted to receive such positive feedback from Pal International’s in-country partners,” adds Katarzyna. “It reaffirms our unwavering commitment to our clients’ success. We look forward to continuing to leverage our expertise to support Pal International with their international activities and expansion efforts.”

Pal International represents the latest addition to the growing number of Mastermind Translations’ high-profile clients, drawn to its deep understanding of their industry and ability to alleviate operational burdens. Among its recent clients are global pharmaceutical companies medac and HIPRA.

Pal International and Mastermind Translations extend their gratitude to Medilink Midlands for making this successful collaboration possible and look forward to expanding their international network further at the upcoming Innovation Day 2024.

 

Article provided by Medilink Midlands member Mastermind Translations.

Latest Opportunities

Single manufacturer & supplier required for human skin patch: Formulation, manufacture, and packing

Opportunity Company:  Nottingham-based MedTech company Requires: Seeking a single manufacturer and supplier for the formulation,…

Medilink Midlands Job Vacancy - Innovation Adviser

About the job Innovation Adviser – Midlands region – Full time salary £40-45K – Home…

Global Business Innovation Programme: Health & Medical Technologies - Singapore

Innovate UK is inviting ambitious innovative companies to participate in its Global Business Innovation Programme…

Latest News

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep – Helping Gamers…

Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters…

EU MDR/IVDR Revision: A Gateway for Chinese Innovators Entering UK and EU Markets via EFEC

In a significant move for the global medtech landscape, the European Commission has initiated a…